-
1
-
-
33646859458
-
Ewing's sarcoma family of tumors: Current management
-
16720851 10.1634/theoncologist.11-5-503 1:CAS:528:DC%2BD28XhtFGhu7jF
-
Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H (2006) Ewing's sarcoma family of tumors: current management. Oncologist 11:503-519
-
(2006)
Oncologist
, vol.11
, pp. 503-519
-
-
Bernstein, M.1
Kovar, H.2
Paulussen, M.3
Randall, R.L.4
Schuck, A.5
Teot, L.A.6
Juergens, H.7
-
2
-
-
78649460883
-
Emerging drugs for high-grade osteosarcoma
-
20690888 10.1517/14728214.2010.505603 1:CAS:528:DC%2BC3cXhsVOgtLzF
-
Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M (2010) Emerging drugs for high-grade osteosarcoma. Expert Opin Emerg Drugs 15:615-634
-
(2010)
Expert Opin Emerg Drugs
, vol.15
, pp. 615-634
-
-
Hattinger, C.M.1
Pasello, M.2
Ferrari, S.3
Picci, P.4
Serra, M.5
-
3
-
-
40049108801
-
Incidence of biopsy-proven bone tumors in children: A report based on the Dutch pathology registration "pALGA
-
18157043 10.1097/BPO.0b013e3181558cb5
-
van den Berg H, Kroon HM, Slaar A, Hogendoorn PCW (2008) Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration "PALGA". J Pediatr Orthop 28:29-35
-
(2008)
J Pediatr Orthop
, vol.28
, pp. 29-35
-
-
Van Den Berg, H.1
Kroon, H.M.2
Slaar, A.3
Hogendoorn, P.C.W.4
-
4
-
-
84875461928
-
Histone Deacetylase Inhibitors Enhance Expression of NKG2D Ligands in Ewing Sarcoma and Sensitize for Natural Killer Cell-Mediated Cytolysis
-
Berghuis D, Schilham M.W., Voss HI, Santos SJ, Kloess S, Buddingh EP, Egeler RM, Hogendoorn PCW, Lankester AC (2012) Histone Deacetylase Inhibitors Enhance Expression of NKG2D Ligands in Ewing Sarcoma and Sensitize for Natural Killer Cell-Mediated Cytolysis. Clin Sarcoma Res 2:8
-
(2012)
Clin Sarcoma Res
, vol.2
, pp. 8
-
-
Berghuis, D.1
Schilham, M.W.2
Voss, H.I.3
Santos, S.J.4
Kloess, S.5
Buddingh, E.P.6
Egeler, R.M.7
Hogendoorn, P.C.W.8
Lankester, A.C.9
-
5
-
-
79953805065
-
Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells
-
21240486 10.1007/s00262-010-0965-3 1:CAS:528:DC%2BC3MXjsFyqu70%3D
-
Buddingh EP, Schilham MW, Ruslan SE, Berghuis D, Szuhai K, Suurmond J, Taminiau AH, Gelderblom H, Egeler RM, Serra M, Hogendoorn PCW, Lankester AC (2011) Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells. Cancer Immunol Immunother 60:575-586
-
(2011)
Cancer Immunol Immunother
, vol.60
, pp. 575-586
-
-
Buddingh, E.P.1
Schilham, M.W.2
Ruslan, S.E.3
Berghuis, D.4
Szuhai, K.5
Suurmond, J.6
Taminiau, A.H.7
Gelderblom, H.8
Egeler, R.M.9
Serra, M.10
Hogendoorn, P.C.W.11
Lankester, A.C.12
-
6
-
-
84856015456
-
Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma
-
22090361 10.1158/1078-0432.CCR-11-2277 1:CAS:528:DC%2BC38XhtVGqsrw%3D
-
Pahl JH, Ruslan SE, Buddingh EP, Santos SJ, Szuhai K, Serra M, Gelderblom H, Hogendoorn PC, Egeler RM, Schilham MW, Lankester AC (2012) Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma. Clin Cancer Res 18:432-441
-
(2012)
Clin Cancer Res
, vol.18
, pp. 432-441
-
-
Pahl, J.H.1
Ruslan, S.E.2
Buddingh, E.P.3
Santos, S.J.4
Szuhai, K.5
Serra, M.6
Gelderblom, H.7
Hogendoorn, P.C.8
Egeler, R.M.9
Schilham, M.W.10
Lankester, A.C.11
-
7
-
-
49649119363
-
NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
-
18657862 10.1016/j.molimm.2008.06.016 1:CAS:528:DC%2BD1cXhtVaisLjE
-
Verhoeven DHJ, de Hooge AS, Mooiman EC, Santos SJ, ten Dam MM, Gelderblom H, Melief CJ, Hogendoorn PCW, Egeler RM, van Tol MJD, Schilham MW, Lankester AC (2008) NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways. Mol Immunol 45:3917-3925
-
(2008)
Mol Immunol
, vol.45
, pp. 3917-3925
-
-
Verhoeven, D.H.J.1
De Hooge, A.S.2
Mooiman, E.C.3
Santos, S.J.4
Ten Dam, M.M.5
Gelderblom, H.6
Melief, C.J.7
Hogendoorn, P.C.W.8
Egeler, R.M.9
Van Tol, M.J.D.10
Schilham, M.W.11
Lankester, A.C.12
-
8
-
-
45449115527
-
Line of attack: NK cell specificity and integration of signals
-
18439809 10.1016/j.coi.2008.03.005 1:CAS:528:DC%2BD1cXns1aht7k%3D
-
Bryceson YT, Long EO (2008) Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 20:344-352
-
(2008)
Curr Opin Immunol
, vol.20
, pp. 344-352
-
-
Bryceson, Y.T.1
Long, E.O.2
-
9
-
-
33744539802
-
Surface NK receptors and their ligands on tumor cells
-
16730454 10.1016/j.smim.2006.03.002 1:CAS:528:DC%2BD28XltlKnu7w%3D
-
Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A (2006) Surface NK receptors and their ligands on tumor cells. Semin Immunol 18:151-158
-
(2006)
Semin Immunol
, vol.18
, pp. 151-158
-
-
Moretta, L.1
Bottino, C.2
Pende, D.3
Castriconi, R.4
Mingari, M.C.5
Moretta, A.6
-
10
-
-
42449151214
-
Functions of natural killer cells
-
18425107 10.1038/ni1582 1:CAS:528:DC%2BD1cXkvVOqu78%3D
-
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9:503-510
-
(2008)
Nat Immunol
, vol.9
, pp. 503-510
-
-
Vivier, E.1
Tomasello, E.2
Baratin, M.3
Walzer, T.4
Ugolini, S.5
-
11
-
-
84859159747
-
NK cell MHC class i specific receptors (KIR): From biology to clinical intervention
-
22264929 10.1016/j.coi.2012.01.001 1:CAS:528:DC%2BC38XltVanu7g%3D
-
Thielens A, Vivier E, Romagne F (2012) NK cell MHC class i specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 24:239-245
-
(2012)
Curr Opin Immunol
, vol.24
, pp. 239-245
-
-
Thielens, A.1
Vivier, E.2
Romagne, F.3
-
12
-
-
0032473478
-
Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class i signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
-
9480992 10.1084/jem.187.5.813 1:CAS:528:DyaK1cXhs1anurg%3D
-
Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813-818
-
(1998)
J Exp Med
, vol.187
, pp. 813-818
-
-
Borrego, F.1
Ulbrecht, M.2
Weiss, E.H.3
Coligan, J.E.4
Brooks, A.G.5
-
13
-
-
3142781416
-
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D
-
15240696 1:CAS:528:DC%2BD2cXlsVGisrg%3D
-
Bacon L, Eagle RA, Meyer M, Easom N, Young NT, Trowsdale J (2004) Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 173:1078-1084
-
(2004)
J Immunol
, vol.173
, pp. 1078-1084
-
-
Bacon, L.1
Eagle, R.A.2
Meyer, M.3
Easom, N.4
Young, N.T.5
Trowsdale, J.6
-
14
-
-
0033618504
-
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
-
10426993 10.1126/science.285.5428.727 1:CAS:528:DyaK1MXltVehsro%3D
-
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729
-
(1999)
Science
, vol.285
, pp. 727-729
-
-
Bauer, S.1
Groh, V.2
Wu, J.3
Steinle, A.4
Phillips, J.H.5
Lanier, L.L.6
Spies, T.7
-
15
-
-
0038745605
-
ULBP4 is a novel ligand for human NKG2D
-
12732206 10.1016/S0006-291X(03)00714-9
-
Chalupny NJ, Sutherland CL, Lawrence WA, Rein-Weston A, Cosman D (2003) ULBP4 is a novel ligand for human NKG2D. Biochem Biophys Res Commun 305:129-135
-
(2003)
Biochem Biophys Res Commun
, vol.305
, pp. 129-135
-
-
Chalupny, N.J.1
Sutherland, C.L.2
Lawrence, W.A.3
Rein-Weston, A.4
Cosman, D.5
-
16
-
-
0035099068
-
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
-
11239445 10.1016/S1074-7613(01)00095-4 1:CAS:528:DC%2BD3MXivFOqurw%3D
-
Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133
-
(2001)
Immunity
, vol.14
, pp. 123-133
-
-
Cosman, D.1
Mullberg, J.2
Sutherland, C.L.3
Chin, W.4
Armitage, R.5
Fanslow, W.6
Kubin, M.7
Chalupny, N.J.8
-
17
-
-
70449368140
-
ULBP6/RAET1L is an additional human NKG2D ligand
-
19658097 10.1002/eji.200939502 1:CAS:528:DC%2BD1MXhsFWhtbfM
-
Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J (2009) ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 39:3207-3216
-
(2009)
Eur J Immunol
, vol.39
, pp. 3207-3216
-
-
Eagle, R.A.1
Traherne, J.A.2
Hair, J.R.3
Jafferji, I.4
Trowsdale, J.5
-
18
-
-
0042922822
-
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
-
12913096 10.1084/jem.20030788 1:CAS:528:DC%2BD3sXms1Wis7c%3D
-
Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, Vitale M, Moretta L, Lopez M, Moretta A (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557-567
-
(2003)
J Exp Med
, vol.198
, pp. 557-567
-
-
Bottino, C.1
Castriconi, R.2
Pende, D.3
Rivera, P.4
Nanni, M.5
Carnemolla, B.6
Cantoni, C.7
Grassi, J.8
Marcenaro, S.9
Reymond, N.10
Vitale, M.11
Moretta, L.12
Lopez, M.13
Moretta, A.14
-
19
-
-
67650507057
-
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
-
19528259 10.1084/jem.20090681 1:CAS:528:DC%2BD1MXos1eisL8%3D
-
Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD (2009) The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206:1495-1503
-
(2009)
J Exp Med
, vol.206
, pp. 1495-1503
-
-
Brandt, C.S.1
Baratin, M.2
Yi, E.C.3
Kennedy, J.4
Gao, Z.5
Fox, B.6
Haldeman, B.7
Ostrander, C.D.8
Kaifu, T.9
Chabannon, C.10
Moretta, A.11
West, R.12
Xu, W.13
Vivier, E.14
Levin, S.D.15
-
20
-
-
30144443832
-
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
-
16150947 10.1182/blood-2005-04-1351 1:CAS:528:DC%2BD28XhsVGntA%3D%3D
-
Bryceson YT, March ME, Ljunggren HG, Long EO (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107:159-166
-
(2006)
Blood
, vol.107
, pp. 159-166
-
-
Bryceson, Y.T.1
March, M.E.2
Ljunggren, H.G.3
Long, E.O.4
-
21
-
-
36248957695
-
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
-
17952078 10.1038/ni1524 1:CAS:528:DC%2BD2sXhtlajtr%2FJ
-
Horng T, Bezbradica JS, Medzhitov R (2007) NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat Immunol 8:1345-1352
-
(2007)
Nat Immunol
, vol.8
, pp. 1345-1352
-
-
Horng, T.1
Bezbradica, J.S.2
Medzhitov, R.3
-
22
-
-
34247100277
-
Dendritic cells prime natural killer cells by trans-presenting interleukin 15
-
17398124 10.1016/j.immuni.2007.03.006 1:CAS:528:DC%2BD2sXltVKjs7Y%3D
-
Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26:503-517
-
(2007)
Immunity
, vol.26
, pp. 503-517
-
-
Lucas, M.1
Schachterle, W.2
Oberle, K.3
Aichele, P.4
Diefenbach, A.5
-
23
-
-
0035949563
-
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
-
11562472 10.1073/pnas.201238598 1:CAS:528:DC%2BD3MXnt12jsrw%3D
-
Cerwenka A, Baron JL, Lanier LL (2001) Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A 98:11521-11526
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 11521-11526
-
-
Cerwenka, A.1
Baron, J.L.2
Lanier, L.L.3
-
24
-
-
0035855872
-
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
-
11557981 10.1038/35093109 1:CAS:528:DC%2BD3MXntVOqtrk%3D
-
Diefenbach A, Jensen ER, Jamieson AM, Raulet DH (2001) Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413:165-171
-
(2001)
Nature
, vol.413
, pp. 165-171
-
-
Diefenbach, A.1
Jensen, E.R.2
Jamieson, A.M.3
Raulet, D.H.4
-
25
-
-
0036143496
-
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection
-
11743585 10.1038/ni746 1:CAS:528:DC%2BD38XktlCltA%3D%3D
-
Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3:83-90
-
(2002)
Nat Immunol
, vol.3
, pp. 83-90
-
-
Kelly, J.M.1
Darcy, P.K.2
Markby, J.L.3
Godfrey, D.I.4
Takeda, K.5
Yagita, H.6
Smyth, M.J.7
-
26
-
-
24344479617
-
NKG2D function protects the host from tumor initiation
-
16129707 10.1084/jem.20050994 1:CAS:528:DC%2BD2MXhtVSjs7%2FF
-
Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y (2005) NKG2D function protects the host from tumor initiation. J Exp Med 202:583-588
-
(2005)
J Exp Med
, vol.202
, pp. 583-588
-
-
Smyth, M.J.1
Swann, J.2
Cretney, E.3
Zerafa, N.4
Yokoyama, W.M.5
Hayakawa, Y.6
-
27
-
-
0037086131
-
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
-
11896281 10.1126/science.1068440 1:CAS:528:DC%2BD38Xit1Ohurs%3D
-
Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100
-
(2002)
Science
, vol.295
, pp. 2097-2100
-
-
Ruggeri, L.1
Capanni, M.2
Urbani, E.3
Perruccio, K.4
Shlomchik, W.D.5
Tosti, A.6
Posati, S.7
Rogaia, D.8
Frassoni, F.9
Aversa, F.10
Martelli, M.F.11
Velardi, A.12
-
28
-
-
0347627712
-
Evasion from NK cell immunity by MHC class i chain-related molecules expressing colon adenocarcinoma
-
14662896 1:CAS:528:DC%2BD3sXpsV2rur0%3D
-
Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM (2003) Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 171:6891-6899
-
(2003)
J Immunol
, vol.171
, pp. 6891-6899
-
-
Doubrovina, E.S.1
Doubrovin, M.M.2
Vider, E.3
Sisson, R.B.4
O'Reilly, R.J.5
Dupont, B.6
Vyas, Y.M.7
-
29
-
-
84864131272
-
Comprehensive analysis of nkg2d ligand expression and release in leukemia: Implications for NKG2D-mediated NK cell responses
-
22730533 10.4049/jimmunol.1200796 1:CAS:528:DC%2BC38XhtVKltbbK
-
Hilpert J, Grosse-Hovest L, Grunebach F, Buechele C, Nuebling T, Raum T, Steinle A, Salih HR (2012) Comprehensive analysis of nkg2d ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J Immunol 189:1360-1371
-
(2012)
J Immunol
, vol.189
, pp. 1360-1371
-
-
Hilpert, J.1
Grosse-Hovest, L.2
Grunebach, F.3
Buechele, C.4
Nuebling, T.5
Raum, T.6
Steinle, A.7
Salih, H.R.8
-
30
-
-
77954107953
-
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells
-
19801517 10.4049/jimmunol.0901226 1:CAS:528:DC%2BD1MXht1WhsLnL
-
Carlsten M, Norell H, Bryceson YT, Poschke I, Schedvins K, Ljunggren HG, Kiessling R, Malmberg KJ (2009) Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol 183:4921-4930
-
(2009)
J Immunol
, vol.183
, pp. 4921-4930
-
-
Carlsten, M.1
Norell, H.2
Bryceson, Y.T.3
Poschke, I.4
Schedvins, K.5
Ljunggren, H.G.6
Kiessling, R.7
Malmberg, K.J.8
-
31
-
-
0037126310
-
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
-
12384702 10.1038/nature01112 1:CAS:528:DC%2BD38XnvVyrt7o%3D
-
Groh V, Wu J, Yee C, Spies T (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734-738
-
(2002)
Nature
, vol.419
, pp. 734-738
-
-
Groh, V.1
Wu, J.2
Yee, C.3
Spies, T.4
-
32
-
-
0037241472
-
Impairment of NK cell function by NKG2D modulation in NOD mice
-
12530974 10.1016/S1074-7613(02)00505-8 1:CAS:528:DC%2BD3sXnvVyrsQ%3D%3D
-
Ogasawara K, Hamerman JA, Hsin H, Chikuma S, Bour-Jordan H, Chen T, Pertel T, Carnaud C, Bluestone JA, Lanier LL (2003) Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18:41-51
-
(2003)
Immunity
, vol.18
, pp. 41-51
-
-
Ogasawara, K.1
Hamerman, J.A.2
Hsin, H.3
Chikuma, S.4
Bour-Jordan, H.5
Chen, T.6
Pertel, T.7
Carnaud, C.8
Bluestone, J.A.9
Lanier, L.L.10
-
33
-
-
24944500112
-
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
-
16116470 10.1038/ni1239 1:CAS:528:DC%2BD2MXos1eqtL0%3D
-
Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6:928-937
-
(2005)
Nat Immunol
, vol.6
, pp. 928-937
-
-
Oppenheim, D.E.1
Roberts, S.J.2
Clarke, S.L.3
Filler, R.4
Lewis, J.M.5
Tigelaar, R.E.6
Girardi, M.7
Hayday, A.C.8
-
34
-
-
0037388134
-
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells
-
12646700 10.1073/pnas.0730640100 1:CAS:528:DC%2BD3sXivFWjsr4%3D
-
Castriconi R, Cantoni C, Della CM, Vitale M, Marcenaro E, Conte R, Biassoni R, Bottino C, Moretta L, Moretta A (2003) Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 100:4120-4125
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 4120-4125
-
-
Castriconi, R.1
Cantoni, C.2
Della, C.M.3
Vitale, M.4
Marcenaro, E.5
Conte, R.6
Biassoni, R.7
Bottino, C.8
Moretta, L.9
Moretta, A.10
-
35
-
-
0022617915
-
Effects of transforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness
-
2871107 1:CAS:528:DyaL28XktVCqt7g%3D
-
Rook AH, Kehrl JH, Wakefield LM, Roberts AB, Sporn MB, Burlington DB, Lane HC, Fauci AS (1986) Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916-3920
-
(1986)
J Immunol
, vol.136
, pp. 3916-3920
-
-
Rook, A.H.1
Kehrl, J.H.2
Wakefield, L.M.3
Roberts, A.B.4
Sporn, M.B.5
Burlington, D.B.6
Lane, H.C.7
Fauci, A.S.8
-
36
-
-
34547686145
-
Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2
-
17671216 10.1158/0008-5472.CAN-06-3456 1:CAS:528:DC%2BD2sXosVemtLc%3D
-
Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z (2007) Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 67:7458-7466
-
(2007)
Cancer Res
, vol.67
, pp. 7458-7466
-
-
Clayton, A.1
Mitchell, J.P.2
Court, J.3
Mason, M.D.4
Tabi, Z.5
-
37
-
-
47249144117
-
Human tumor-derived exosomes down-modulate NKG2D expression
-
18490724 1:CAS:528:DC%2BD1cXmtVantbo%3D
-
Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z (2008) Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 180:7249-7258
-
(2008)
J Immunol
, vol.180
, pp. 7249-7258
-
-
Clayton, A.1
Mitchell, J.P.2
Court, J.3
Linnane, S.4
Mason, M.D.5
Tabi, Z.6
-
38
-
-
80052434130
-
Human tumour immune evasion via TGF-beta blocks nk cell activation but not survival allowing therapeutic restoration of anti-tumour activity
-
21909397 10.1371/journal.pone.0022842 1:CAS:528:DC%2BC3MXht1ent7nE
-
Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP (2011) Human tumour immune evasion via TGF-beta blocks nk cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS One 6:e22842
-
(2011)
PLoS One
, vol.6
, pp. 22842
-
-
Wilson, E.B.1
El-Jawhari, J.J.2
Neilson, A.L.3
Hall, G.D.4
Melcher, A.A.5
Meade, J.L.6
Cook, G.P.7
-
39
-
-
53549114206
-
NK cells and cancer immunosurveillance
-
18836474 10.1038/onc.2008.267 1:CAS:528:DC%2BD1cXhtF2msbnE
-
Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27:5932-5943
-
(2008)
Oncogene
, vol.27
, pp. 5932-5943
-
-
Waldhauer, I.1
Steinle, A.2
-
40
-
-
23944519927
-
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
-
15886320 10.1182/blood-2005-03-0918 1:CAS:528:DC%2BD2MXps1Ogtr8%3D
-
Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W (2005) Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 106:1711-1717
-
(2005)
Blood
, vol.106
, pp. 1711-1717
-
-
Coudert, J.D.1
Zimmer, J.2
Tomasello, E.3
Cebecauer, M.4
Colonna, M.5
Vivier, E.6
Held, W.7
-
41
-
-
43549123826
-
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
-
18198346 10.1182/blood-2007-07-100057 1:CAS:528:DC%2BD1cXktlWmsLY%3D
-
Coudert JD, Scarpellino L, Gros F, Vivier E, Held W (2008) Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood 111:3571-3578
-
(2008)
Blood
, vol.111
, pp. 3571-3578
-
-
Coudert, J.D.1
Scarpellino, L.2
Gros, F.3
Vivier, E.4
Held, W.5
-
42
-
-
78650642570
-
NKG2D initiates caspase-mediated CD3{zeta} degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease
-
20926796 10.4049/jimmunol.1002092 1:CAS:528:DC%2BC3cXhtlOhsbzN
-
Hanaoka N, Jabri B, Dai Z, Ciszewski C, Stevens AM, Yee C, Nakakuma H, Spies T, Groh V (2010) NKG2D initiates caspase-mediated CD3{zeta} degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease. J Immunol 185:5732-5742
-
(2010)
J Immunol
, vol.185
, pp. 5732-5742
-
-
Hanaoka, N.1
Jabri, B.2
Dai, Z.3
Ciszewski, C.4
Stevens, A.M.5
Yee, C.6
Nakakuma, H.7
Spies, T.8
Groh, V.9
-
43
-
-
67650239847
-
The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation
-
19329438 10.1074/jbc.M808561200 1:CAS:528:DC%2BD1MXmvFSjtLk%3D
-
Roda-Navarro P, Reyburn HT (2009) The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation. J Biol Chem 284:16463-16472
-
(2009)
J Biol Chem
, vol.284
, pp. 16463-16472
-
-
Roda-Navarro, P.1
Reyburn, H.T.2
-
44
-
-
84858202941
-
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity
-
22258454 10.1158/0008-5472.CAN-11-2544 1:CAS:528:DC%2BC38XktVanur4%3D
-
Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC (2012) Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 72:1407-1415
-
(2012)
Cancer Res
, vol.72
, pp. 1407-1415
-
-
Pietra, G.1
Manzini, C.2
Rivara, S.3
Vitale, M.4
Cantoni, C.5
Petretto, A.6
Balsamo, M.7
Conte, R.8
Benelli, R.9
Minghelli, S.10
Solari, N.11
Gualco, M.12
Queirolo, P.13
Moretta, L.14
Mingari, M.C.15
-
45
-
-
73949125660
-
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
-
19934056 10.1073/pnas.0906481106 1:CAS:528:DC%2BC3cXksFOrsA%3D%3D
-
Balsamo M, Scordamaglia F, Pietra G, Manzini C, Cantoni C, Boitano M, Queirolo P, Vermi W, Facchetti F, Moretta A, Moretta L, Mingari MC, Vitale M (2009) Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity. Proc Natl Acad Sci U S A 106:20847-20852
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 20847-20852
-
-
Balsamo, M.1
Scordamaglia, F.2
Pietra, G.3
Manzini, C.4
Cantoni, C.5
Boitano, M.6
Queirolo, P.7
Vermi, W.8
Facchetti, F.9
Moretta, A.10
Moretta, L.11
Mingari, M.C.12
Vitale, M.13
-
46
-
-
77953111633
-
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked
-
10.1007/s00262-009-0807-3
-
von Lilienfeld-Toal M, Frank S, Leyendecker C, Feyler S, Jarmin S, Morgan R, Glasmacher A, Marten A, Schmidt-Wolf IG, Brossart P, Cook G (2009) Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked. Cancer Immunol Immunother 59:829-839
-
(2009)
Cancer Immunol Immunother
, vol.59
, pp. 829-839
-
-
Von Lilienfeld-Toal, M.1
Frank, S.2
Leyendecker, C.3
Feyler, S.4
Jarmin, S.5
Morgan, R.6
Glasmacher, A.7
Marten, A.8
Schmidt-Wolf, I.G.9
Brossart, P.10
Cook, G.11
-
47
-
-
0037093066
-
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
-
11986221 10.1182/blood.V99.10.3661 1:CAS:528:DC%2BD38XjvVGnsLc%3D
-
Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D, Gastaut JA, Pende D, Olive D, Moretta A (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99:3661-3667
-
(2002)
Blood
, vol.99
, pp. 3661-3667
-
-
Costello, R.T.1
Sivori, S.2
Marcenaro, E.3
Lafage-Pochitaloff, M.4
Mozziconacci, M.J.5
Reviron, D.6
Gastaut, J.A.7
Pende, D.8
Olive, D.9
Moretta, A.10
-
48
-
-
33845987986
-
Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction
-
16940427 10.1182/blood-2005-08-027979 1:CAS:528:DC%2BD2sXivVyru7o%3D
-
Fauriat C, Just-Landi S, Mallet F, Arnoulet C, Sainty D, Olive D, Costello RT (2007) Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109:323-330
-
(2007)
Blood
, vol.109
, pp. 323-330
-
-
Fauriat, C.1
Just-Landi, S.2
Mallet, F.3
Arnoulet, C.4
Sainty, D.5
Olive, D.6
Costello, R.T.7
-
49
-
-
27144524046
-
NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors
-
Le Maux CB, Moretta A, Vergnon I, Opolon P, Lecluse Y, Grunenwald D, Kubin M, Soria JC, Chouaib S, Mami-Chouaib F (2005) NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors. J Immunol 175:5790-5798
-
(2005)
J Immunol
, vol.175
, pp. 5790-5798
-
-
Le Maux, C.B.1
Moretta, A.2
Vergnon, I.3
Opolon, P.4
Lecluse, Y.5
Grunenwald, D.6
Kubin, M.7
Soria, J.C.8
Chouaib, S.9
Mami-Chouaib, F.10
-
50
-
-
2942588777
-
Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
-
15187109 1:CAS:528:DC%2BD2cXks1ahtbw%3D
-
Lee JC, Lee KM, Kim DW, Heo DS (2004) Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172:7335-7340
-
(2004)
J Immunol
, vol.172
, pp. 7335-7340
-
-
Lee, J.C.1
Lee, K.M.2
Kim, D.W.3
Heo, D.S.4
-
51
-
-
80053465574
-
Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression
-
21844012 10.1158/1078-0432.CCR-11-1347 1:CAS:528:DC%2BC3MXht1Ggs7nE
-
Parkhurst MR, Riley JP, Dudley ME, Rosenberg SA (2011) Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 17:6287-6297
-
(2011)
Clin Cancer Res
, vol.17
, pp. 6287-6297
-
-
Parkhurst, M.R.1
Riley, J.P.2
Dudley, M.E.3
Rosenberg, S.A.4
-
52
-
-
84872225254
-
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
-
23209317 10.1084/jem.20120944 1:CAS:528:DC%2BC38XhvVOitbzK
-
Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A (2012) Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 209:2351-2365
-
(2012)
J Exp Med
, vol.209
, pp. 2351-2365
-
-
Ni, J.1
Miller, M.2
Stojanovic, A.3
Garbi, N.4
Cerwenka, A.5
-
53
-
-
0037108686
-
Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer
-
12384543 1:CAS:528:DC%2BD38XotFykt74%3D
-
Kono K, Takahashi A, Ichihara F, Sugai H, Fujii H, Matsumoto Y (2002) Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer. Cancer Res 62:5813-5817
-
(2002)
Cancer Res
, vol.62
, pp. 5813-5817
-
-
Kono, K.1
Takahashi, A.2
Ichihara, F.3
Sugai, H.4
Fujii, H.5
Matsumoto, Y.6
|